Bactolife A/S: Financial statements 2022
CVR: 38879073
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Bactolife A/S (CVR 38879073) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 333,298 and a net result of DKK -27,568,140 compared with DKK -8,224,173 the year before. That is a decrease of 77.5% compared with the year before. The profit margin was -8,271.3%. Equity in the 2022 report amounted to DKK 23,888,811. The solvency ratio was 28.3%. The company had 22 employees in the financial year.
- Revenue
- DKK 333,298
- Gross Profit
- DKK -9,116,586
- Profit/Loss
- DKK -27,568,140
- Equity
- DKK 23,888,811
- Total Assets
- DKK 84,338,455
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 333 t. | -9.1 mio. | -27.6 mio. | 23.9 mio. | 22 |
| 2021 | 1.5 mio. | -2.1 mio. | -8.2 mio. | 51.5 mio. | 8 |
| 2020 | - | -1.3 mio. | -2.7 mio. | 6.9 mio. | 2 |
| 2019 | - | -1.3 mio. | -1.6 mio. | -1.2 mio. | 1 |
Official annual report
Keep an eye on Bactolife A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 31, 2022, Claus Sebastian Søderberg has stepped down as director of Bactolife A/S.
Bactolife A/S has published its annual report for 2021. Revenue came to DKK 1,483,885, and the net result was DKK -8,224,173.
On May 27, 2022, the company changed its name from Bactolife ApS to Bactolife A/S.
As of April 1, 2022, Claus Sebastian Søderberg is registered as director of Bactolife A/S.
About Bactolife A/S
Bactolife A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named Bactolife ApS. The management consists of Claus Sebastian Søderberg. The board consists of Jørgen Rugholm Jensen (chair), Donna Margaret Parr, Frank Julian Zachmann and Mads Aage Laustsen. The company's owners include SELFINVEST ApS, MR BIOINVEST ApS and Novo Holdings A/S. The company has 51 employees (2026). In 2025, the company reported a gross profit of DKK -36,029,363 and a net result of DKK -74,004,944 compared with DKK -49,229,351 the year before. Equity in the 2025 report amounted to DKK 203,677,089.